Conversely, some previous studies52, 54 failed to observe any tau pathology in AD retinas, which may be attributed to differences in sample size, use of non‐optimal techniques, limited anatomical regions analysis, or the use of varying tau isoform‐specific markers. This evidence concerns the gene MAPT and Alzheimer disease.